Cargando…

Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model

BACKGROUND: Osteochondral defects continue to be a clinical treatment challenge, and when left untreated, may cause pain and functional impairment. Pyrolytic carbon is a unique isotropic biomaterial used in heart valve and small joint replacements due to its excellent wear properties and biocompatib...

Descripción completa

Detalles Bibliográficos
Autores principales: Salkeld, Samantha L., Patron, Laura P., Lien, Joan C., Cook, Stephen D., Jones, Deryk G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133767/
https://www.ncbi.nlm.nih.gov/pubmed/27906096
http://dx.doi.org/10.1186/s13018-016-0488-5
_version_ 1782471333698863104
author Salkeld, Samantha L.
Patron, Laura P.
Lien, Joan C.
Cook, Stephen D.
Jones, Deryk G.
author_facet Salkeld, Samantha L.
Patron, Laura P.
Lien, Joan C.
Cook, Stephen D.
Jones, Deryk G.
author_sort Salkeld, Samantha L.
collection PubMed
description BACKGROUND: Osteochondral defects continue to be a clinical treatment challenge, and when left untreated, may cause pain and functional impairment. Pyrolytic carbon is a unique isotropic biomaterial used in heart valve and small joint replacements due to its excellent wear properties and biocompatibility with bone and articular cartilage. Therefore, a proposed solution is to utilize a focal pyrolytic carbon hemiarthroplasty implant as an alternative resurfacing treatment strategy for isolated cartilage lesions. METHODS: A canine model (n = 9) was used to evaluate the in vivo histologic response and function of a pyrolytic carbon implant replacing a full-thickness osteochondral defect in the medial femoral condyle (MFC) of the knee. The gross appearance and histologic results were compared to an identical cobalt-chromium (Co-Cr) alloy implant placed in a defect in the contralateral MFC and evaluated up to 52 weeks. RESULTS: Extensive bone incorporation to the stem portion was observed for both implant types. The total mean histologic score for the cartilage of the MFC surrounding the pyrolytic carbon implants was significantly improved compared to that of the Co-Cr alloy implants at all evaluation periods (p < 0.05). Histologic grading and gross observations at 52 weeks for pyrolytic carbon implants were similar to those of Co-Cr alloy implants at 24 weeks. At 24 weeks, the mean total histologic score for Co-Cr alloy implants was 11.6 ± 0.7 (0–16 range point; 16 = normal appearance), while at 52 weeks, the mean total score for the pyrolytic carbon implants was 11.7 ± 1.3. Mean total histologic score of opposing medial tibia cartilage for the pyrolytic carbon implants was superior to that of the Co-Cr alloy group at all evaluation periods and significantly improved over the Co-Cr alloy implant group at 24 weeks (p = 0.001) and 52 weeks (p < 0.001). CONCLUSIONS: Use of a pyrolytic carbon implant for reconstruction of a focal cartilage defect demonstrated effective implant fixation and superior in vivo response compared to an identical Co-Cr alloy implant.
format Online
Article
Text
id pubmed-5133767
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51337672016-12-15 Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model Salkeld, Samantha L. Patron, Laura P. Lien, Joan C. Cook, Stephen D. Jones, Deryk G. J Orthop Surg Res Research Article BACKGROUND: Osteochondral defects continue to be a clinical treatment challenge, and when left untreated, may cause pain and functional impairment. Pyrolytic carbon is a unique isotropic biomaterial used in heart valve and small joint replacements due to its excellent wear properties and biocompatibility with bone and articular cartilage. Therefore, a proposed solution is to utilize a focal pyrolytic carbon hemiarthroplasty implant as an alternative resurfacing treatment strategy for isolated cartilage lesions. METHODS: A canine model (n = 9) was used to evaluate the in vivo histologic response and function of a pyrolytic carbon implant replacing a full-thickness osteochondral defect in the medial femoral condyle (MFC) of the knee. The gross appearance and histologic results were compared to an identical cobalt-chromium (Co-Cr) alloy implant placed in a defect in the contralateral MFC and evaluated up to 52 weeks. RESULTS: Extensive bone incorporation to the stem portion was observed for both implant types. The total mean histologic score for the cartilage of the MFC surrounding the pyrolytic carbon implants was significantly improved compared to that of the Co-Cr alloy implants at all evaluation periods (p < 0.05). Histologic grading and gross observations at 52 weeks for pyrolytic carbon implants were similar to those of Co-Cr alloy implants at 24 weeks. At 24 weeks, the mean total histologic score for Co-Cr alloy implants was 11.6 ± 0.7 (0–16 range point; 16 = normal appearance), while at 52 weeks, the mean total score for the pyrolytic carbon implants was 11.7 ± 1.3. Mean total histologic score of opposing medial tibia cartilage for the pyrolytic carbon implants was superior to that of the Co-Cr alloy group at all evaluation periods and significantly improved over the Co-Cr alloy implant group at 24 weeks (p = 0.001) and 52 weeks (p < 0.001). CONCLUSIONS: Use of a pyrolytic carbon implant for reconstruction of a focal cartilage defect demonstrated effective implant fixation and superior in vivo response compared to an identical Co-Cr alloy implant. BioMed Central 2016-12-01 /pmc/articles/PMC5133767/ /pubmed/27906096 http://dx.doi.org/10.1186/s13018-016-0488-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Salkeld, Samantha L.
Patron, Laura P.
Lien, Joan C.
Cook, Stephen D.
Jones, Deryk G.
Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title_full Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title_fullStr Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title_full_unstemmed Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title_short Biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
title_sort biological and functional evaluation of a novel pyrolytic carbon implant for the treatment of focal osteochondral defects in the medial femoral condyle: assessment in a canine model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133767/
https://www.ncbi.nlm.nih.gov/pubmed/27906096
http://dx.doi.org/10.1186/s13018-016-0488-5
work_keys_str_mv AT salkeldsamanthal biologicalandfunctionalevaluationofanovelpyrolyticcarbonimplantforthetreatmentoffocalosteochondraldefectsinthemedialfemoralcondyleassessmentinacaninemodel
AT patronlaurap biologicalandfunctionalevaluationofanovelpyrolyticcarbonimplantforthetreatmentoffocalosteochondraldefectsinthemedialfemoralcondyleassessmentinacaninemodel
AT lienjoanc biologicalandfunctionalevaluationofanovelpyrolyticcarbonimplantforthetreatmentoffocalosteochondraldefectsinthemedialfemoralcondyleassessmentinacaninemodel
AT cookstephend biologicalandfunctionalevaluationofanovelpyrolyticcarbonimplantforthetreatmentoffocalosteochondraldefectsinthemedialfemoralcondyleassessmentinacaninemodel
AT jonesderykg biologicalandfunctionalevaluationofanovelpyrolyticcarbonimplantforthetreatmentoffocalosteochondraldefectsinthemedialfemoralcondyleassessmentinacaninemodel